Advertise on podcast: The Robot Investor

Novanta (NASDAQ: NOVT) makes precision motors, drives, encoders and force-torque sensors, the "muscles and nerves" of robots, which puts it in Layer 3 of the robotics stack: actuation and precision motion. In this deep dive, Elena and Theo explain what Novanta actually sells and how much of the company is robotics today: its Robotics and Automation line was $88.4 million of $265.8 million in Q2 2026 revenue, about a third. The bull case: 10% revenue growth, raised 2026 guidance, a growing AI-and-semiconductor slice, and early servo-drive orders for humanoid training facilities. The bear case: a rich valuation, a $1.2 billion Riverpoint Medical acquisition that raises debt and pushes medical to about 60% of sales, medical margin pressure, tariffs, and humanoid deployment that management itself calls a longer-term process. We cover trailing versus forward earnings multiples in plain English, what has to go right, and what to watch: Q3 results after the close on November 9, 2026, new guidance, and whether humanoid training orders turn into production orders. Hosted by AI. Researched and written by AI from credible public sources — we can get things wrong, so verify with primary sources. Not investment advice.

This week on The Robot Investor, the weekly robotics-investing news show for everyday investors. Tesla's third-quarter report (Oct 21) says early Optimus production has begun on a high-volume Fremont line, but gave no output number, and Musk put outside deliveries around the end of 2027; revenue was about 28 billion dollars, flat, while research spending rose 69 percent. Agility Robotics and farm-equipment maker AGCO announced a Digit humanoid pilot at a Kansas plant starting in 2027, with no robot count or terms disclosed. Dream Labs raised a 90 million dollar seed round for Dream-1, a robot foundation model, though the claims lack independent benchmarks. The U.S. Navy raised its Gecko Robotics inspection contract to "up to" 300 million dollars from an initial 54 million dollar deal, and we explain why a ceiling isn't money spent. Our skeptic's segment looks at FieldAI's signed term sheet for 700 million dollars at a 10 billion dollar valuation and a list of private robotics valuations where none of the companies disclose revenue. We also flag what we could not confirm from RoboBusiness and the HD Hyundai Robotics booth in Daegu. Plus what to watch next week. Hosted by AI. Researched and written by AI from credible public sources — we can get things wrong, so verify with primary sources. Not investment advice.

Northrop Grumman (NYSE: NOC) is one of America's biggest defense contractors, and it just flew its self-funded Talon Blue drone wingman fully autonomously for the first time. In this deep dive, Elena and Theo place the company on the defense, drone and aerospace layer of the robotics stack and ask the honest question: is this a robotics stock, or a bomber-and-missile company with a robotics option attached? The bull case: a roughly $109.6 billion backlog, 7% sales growth, raised 2026 earnings guidance, and autonomy software that management says has worked with other companies' systems. The bear case: B-21 fixed-price cost risk (a $477 million charge in April 2025), a crowded drone field where Anduril and General Atomics already won the first production round, and a continuing resolution that can block new production starts. We explain book-to-bill, backlog, fixed-price contracts and basis points in plain English, give our interpretation that robotics is an option here rather than the core, and list what a casual investor should watch next, from the Air Force's Increment 2 decisions to December's Emerald Flag exercise. Hosted by AI. Researched and written by AI from credible public sources — we can get things wrong, so verify with primary sources. Not investment advice.

Synaptics (NASDAQ: SYNA) started with laptop trackpads and now sells edge-AI processors, wireless chips and tactile sensors aimed at robot hands. In this deep dive on Layer 2 of the robotics stack, processing and edge compute, we explain what Synaptics does and why onsemi agreed to buy it, first in a roughly $7 billion all-stock deal in June and then, after an unsolicited rival bid later revealed as Cirrus Logic, in a revised all-cash deal at $123 a share, about $5.7 billion. The bull case: Core IoT revenue grew 43% last fiscal year, a robotics pipeline of 35-plus device makers, and a new tactile sensing module supported in Nvidia Isaac Sim. The bear case: management says robotics content is only a few tens of dollars per platform, with no robotics revenue disclosed, shrinking mobile touch sales, customer concentration, and a stock that now trades on deal risk rather than robots. Our verdict, labelled as interpretation: robotics is a small growth option here, not the thesis. We cover what to watch: the shareholder vote, international regulators, the gap to the offer price, and the Astra chip ramp. Hosted by AI. Researched and written by AI from credible public sources — we can get things wrong, so verify with primary sources. Not investment advice.

This week on The Robot Investor, we break down the humanoid robot scoreboard, a big surgical robotics deal, and a memory chip angle most casual investors miss. IDC data reported by Gasgoo counts close to 25,000 humanoids shipped in the first half of 2026, up 432 percent, with China at about 78 percent and AgiBot leading with over 8,600 units. Stryker invests about 400 million dollars in CMR Surgical and gets an option to buy the rest, building on our recent Stryker deep dive. Agility Robotics pairs Digit 5 with Nyobolt fast charging: 90 minutes of runtime, a nine-minute charge, early access expected in the first half of 2027. Counterpoint Research projects humanoid memory demand could grow about twenty-fold by 2030, and Micron's CEO called physical AI a possible growth driver. Panasonic targets humanoid production by 2029, and HD Hyundai Robotics will show its first prototype at an expo in Daegu on October 21 to 24. Our skeptic segment covers why impressive humanoid demos still fail the generalization test. We also flag what to watch next week, including RoboBusiness and Tesla's scheduled earnings. Hosted by AI. Researched and written by AI from credible public sources — we can get things wrong, so verify with primary sources. Not investment advice.

Lattice Semiconductor (NASDAQ: LSCC) makes small, low-power programmable chips called FPGAs. In robotics, they act like the nervous system around the big AI brain: translating camera data, fusing sensors and controlling motors. That puts Lattice in Layer 2 of our robotics stack, processing and edge compute. In this deep dive, Elena and Theo walk through the record Q2 2026 results ($201 million revenue, up 62% year over year), the $1.65 billion AMI acquisition, and a documented humanoid example with Advantech and NVIDIA's Holoscan Sensor Bridge. The bull case: AI-server demand, strong margins and cash flow, and record design wins including robotics. The bear case: a rich valuation, cyclical industrial demand, integration risk, and heavy Asia and distributor exposure. Our verdict, labeled as interpretation: robotics is an option here, not the core, because Lattice does not disclose robotics revenue. We finish with what would have to be true and what to watch, including the November 2 earnings date. Prices and ratings were checked October 14, 2026 and move fast. Hosted by AI. Researched and written by AI from credible public sources — we can get things wrong, so verify with primary sources. Not investment advice.

Agility Robotics, maker of the Digit warehouse humanoid, is going public through a SPAC merger with Churchill Capital Corp XI (CCXI, future ticker AGLT) at a $2.5 billion pre-money value. A September SEC filing, as reported by The Robot Report, shows about $1.8 million of 2025 revenue and roughly a $140 million operating loss, so the deal values the company at around 1,400 times last year's sales. In this deep dive on Layer 10 of the robotics stack (full-stack humanoids), Elena and Theo explain what a SPAC is and why buying CCXI today is not yet buying a robot company. The bull case: more than $300 million in multi-year Digit v5 orders, nine customer sites, more than 65,000 operating hours, a cooperative-safety design, and a Foxconn-led $200 million private placement. The bear case: heavy cash burn, manufacturing costs that must fall, one-customer order concentration, redemption risk that could shrink the cash raised, well-funded rivals, and the history of volatile post-SPAC stocks. We cover what would have to be true for the thesis to work and what a casual investor should watch next, including the filing updates and the shareholder vote. Hosted by AI. Researched and written by AI from credible public sources — we can get things wrong, so verify with primary sources. Not investment advice.

Agility Robotics' October 6 investor day put numbers on its Digit 5 humanoid ahead of its Churchill Capital Corp XI listing: a bill of materials of about $150,000 at launch versus roughly $125,000 for Digit 4, a $30,000 target only at 10,000 units a year, a 1,000-robot, $300 million order from an unnamed related-party customer, and general availability slipping to the end of 2027. Boston Dynamics named former Amazon Alexa and AGI scientist Rohit Prasad its new chief executive, a signal that the company is betting on physical AI software. Teradyne made an undisclosed strategic investment in Bright Machines for AI data center manufacturing and settled its copyright lawsuit with Elite Robots. Amazon Web Services released an open-source Physical AI Toolchain built with NVIDIA's Isaac Sim, Isaac Lab, GR00T and Cosmos. And contract manufacturer Jabil's engineering director offers a skeptic's reality check: memory and compute costs, unsettled safety certification, and consumer humanoids "five-ish years" away, maybe twenty. Elena and Theo explain the jargon in plain English and ask what it means for a normal brokerage account. Hosted by AI. Researched and written by AI from credible public sources — we can get things wrong, so verify with primary sources. Not investment advice.

Stryker (NYSE: SYK) is a roughly $25 billion medical device company that owns the Mako robot, widely used in knee and hip replacement. In this deep dive on The Robot Investor, Elena and Theo place Stryker in layer 7 of the robotics value chain, medical and surgical robotics, and ask the honest question: is this a robotics stock, or a medical-device business with a robotics moat? The bull case covers early robotic adoption, a record second quarter for Mako installations, the new handheld Mako RPS launch, and strong margins. The bear case covers the March 2026 cyberattack and its lingering effects on vascular supply, softer hip sales, rivals like Johnson & Johnson's Velys and Zimmer Biomet's Rosa, and a September sell-off that left the stock near the bottom of its 52-week range as of October 2. We translate the numbers into plain English, walk through what would have to be true for the thesis to work, and flag what to watch at the October 29 third-quarter report. Not sure where robotics fits in your portfolio? Start here. Hosted by AI. Researched and written by AI from credible public sources — we can get things wrong, so verify with primary sources. Not investment advice.

Schneider Electric just agreed to buy PTC (NASDAQ: PTC) for $205 a share in cash, about $22.6 billion in equity value, a 42.3% premium to the prior close, with closing expected in Q3 2027. Is that a robotics story? In this deep dive, Elena and Theo place PTC on Layer 4 of the robotics value chain: software, simulation and AI platforms. PTC makes the design and product-lifecycle tools (Creo, Windchill, Onshape) that engineers use before a robot is ever built, and in March it announced an Onshape to NVIDIA Isaac Sim workflow for robot design and simulation. The bull case: immediate cash value for shareholders and a strategic "digital thread" from design to factory floor. The bear case: Schneider's own shares fell on the price and debt, analysts flagged integration and AI-disruption worries, and we found no disclosed robotics revenue at PTC, so robotics here is an option, not the core. We cover what has to be true for the thesis to work and what casual investors should watch: the gap between PTC's price and $205, regulatory approvals, and Schneider's financing. Hosted by AI. Researched and written by AI from credible public sources — we can get things wrong, so verify with primary sources. Not investment advice.

The robot industry's annual census is out, and the big money is still in boring robots. The International Federation of Robotics' World Robotics 2026 report counts a record five million industrial robots in factories worldwide, with more than 600,000 installed in 2025. China took 59 percent of installs, and the U.S. passed Japan to become the second-largest market at almost 38,500 units. The Federation's service-robot report adds a reality check: about 7,000 full-size humanoids were sold in 2025, and it cites "the lack of a strong business case" as a key barrier. We also cover a report from The Information, summarized by Electrek, that Tesla's Fremont Optimus line now builds several hundred robots a week while hands, suppliers and AI generalization lag behind, and Tesla's new $30 billion in credit lines from Citibank and Wells Fargo. Plus the Pentagon's new four-star Autonomous Warfare Command and Project Agincourt, SoftBank's $225 million investment in Utah's Autonomous Solutions for self-driving construction fleets, and Figure AI retiring its Figure 02 humanoids in a Finnish steel furnace. One to watch: Agility Robotics' Analyst and Investor Day on October 6 ahead of its Churchill Capital Corp XI merger. Hosted by AI. Researched and written by AI from credible public sources — we can get things wrong, so verify with primary sources. Not investment advice.

Medtronic (NYSE: MDT) is best known for pacemakers and insulin pumps, but its Hugo surgical robot is the first major challenger to Intuitive's da Vinci in the U.S. in more than twenty years. In this deep dive we place Medtronic in Layer 7 of the robotics stack, medical and surgical robotics, and ask the question casual investors need answered: is this a robotics stock, or a robotics option inside a much bigger company? The bull case: a huge addressable market, with general surgery and gynecology far larger than the urology procedures Hugo is cleared for today, pending FDA decisions management expects this fall, a new vessel-sealing instrument, and a roughly $700 million Cornerstone Robotics deal for markets outside the U.S. The bear case: Intuitive's installed base of about 11,700 systems versus roughly 250 Hugo units management expects by fiscal year-end, urology-only U.S. clearance for now, and no Hugo revenue line in Medtronic's reports. We also walk through the September 1 earnings, where heart-ablation growth, not robots, drove the beat. What to watch: the FDA decisions, the November earnings, and the MiniMed separation. Hosted by AI. Researched and written by AI from credible public sources — we can get things wrong, so verify with primary sources. Not investment advice.

The week robotics investing got concrete. On September 22, Cognex (NASDAQ: CGNX) agreed to acquire RealSense — the depth-camera business Intel founded in 2014 and spun out in 2025 — for approximately $500 million in cash, plus a $56.5 million retention program and about $50 million in stock grants. Cognex expects RealSense to generate $80–90 million of revenue in 2026 and sizes robotic perception at roughly $600 million today, growing to about $1.6 billion by 2030. The market disagreed: shares fell about 4.7% to just over $59, and D.A. Davidson's Matthew Summerville held a Neutral rating and a $65 target, calling the price broadly fair. Elena and Theo also cover Boston Dynamics opening its Robotics Metaplant Application Center inside Hyundai's Georgia Metaplant on September 21, where Atlas humanoids are training on part sequencing — against a stated plan for 25,000 Atlas units across Hyundai and Kia plants and a new U.S. factory capable of 30,000 robots a year. Plus Alphabet-owned Intrinsic open-sourcing Intrinsic Core under Apache 2.0; China's rare-earth magnet shipments to the U.S. falling 21% to 512 metric tons in August as Xi Jinping visited Washington and Treasury Secretary Scott Bessent announced the US-China trade truce had been extended from November 10 to January 10; record $100 million-plus Series A rounds including Xpeng Robotics' $900 million; and Chatham House's finding that only about 9% of Unitree's revenue came from industry customers. Depth sensing, teleoperation and Series A rounds explained in plain English. Hosted by AI. Researched and written by AI from credible public sources — we can get things wrong, so verify with primary sources. Not investment advice.

Qualcomm Incorporated (NASDAQ: QCOM) sits on Layer 2 of the robotics stack — processing and edge compute, the silicon brains inside the machine. On September 23, 2026, Qualcomm agreed to acquire PickNik, the Boulder, Colorado company that stewards MoveIt, the open-source motion-planning framework that a very large share of the world's research and commercial robot arms are built on. Terms were not disclosed, and the stock barely moved. Elena and Theo unpack why this matters more than the share price suggests: it is Qualcomm's third robotics-adjacent purchase in under a year, following Arduino in October 2025 and Modular in 2026, and it completes a developer stack that runs from a hobbyist Arduino Ventuno Q board up to Dragonwing industrial silicon already inside humanoids from Booster and VinMotion. The bull case is a deliberate land grab for the default robotics development path, with MoveIt kept open source and cross-platform. The bear case is blunt: Qualcomm does not disclose a single dollar of robotics revenue, handset chips are still over half the business and fell 20% year over year last quarter, Apple is building its own modem, and September's share-price move came from a potential $60 billion Amazon data-centre agreement, not from robots. We give the show's usual honest verdict on whether robotics is core or option here, plus five things a casual investor should watch into the November 4 earnings report. Hosted by AI. Researched and written by AI from credible public sources — we can get things wrong, so verify with primary sources. Not investment advice.

Skild AI is a three-year-old Pittsburgh startup building what it calls an "omni-bodied" AI brain — one model meant to run any robot, from humanoids to warehouse arms, without retraining for every new task. It sits in the software and AI-platform layer of the robotics stack, the same "brain, not body" bet the show explored with Dyna Robotics. Ten months after its first commercial deployment, Skild says it has crossed $100 million in annual recurring revenue, with named customers including NVIDIA and Foxconn (assembling NVIDIA's own Blackwell GPU racks), Sumitomo Wiring Systems, and Mitsui & Co. The company just raised $1.4 billion led by SoftBank at a valuation above $14 billion, and in August released S1, a model that claims to learn brand-new tasks from a single video demonstration. Elena and Theo dig into the bull case — real, named factory deployments and a genuinely novel one-shot learning trick — against the bear case: every performance number and every dollar of that revenue claim comes from Skild's own disclosures, with no independent audit, in an AI "world models" category that a fresh TechCrunch report says is unusually secretive even among insiders. They also cover how a casual investor can get indirect, diluted exposure through NVIDIA and SoftBank, since Skild itself has no ticker. Hosted by AI. Researched and written by AI from credible public sources — we can get things wrong, so verify with primary sources. Not investment advice.